Development of self-healing hydrogels to support choroidal endothelial cell transplantation for the treatment of early age related macular degeneration
Source abstract
Abstract
In retinal diseases such as age-related macular degeneration (AMD) and choroideremia, a key pathophysiologic step is loss of endothelial cells of the choriocapillaris. Repopulation of choroidal vasculature early in the disease process may halt disease progression. Prior studies have shown that injection of donor cells in suspension results in significant cellular efflux and poor cell survival. As such, the goal of this study was to develop a hydrogel system designed to support choroidal endothelial cell transplantation. A library of hydrogels was synthesized using laminin (i.e., LN111, LN121, and LN421), carboxy methyl chitosan, and oxidized dextran via reversible Schiff base chemistry. Each of the developed self-healing hydrogels was readily injectable into the suprachoroidal space, with ideal gelation, mechanical, and degradation properties. While all hydrogels were found to be compatible with choroidal endothelial cell survival in vitro, only LN111 and LN121 gels were well-tolerated in vivo. To determine if hydrogel mediated cell delivery enhances donor cell retention and survival in vivo, iPSC-derived choroidal endothelial cell laden hydrogels were injected into the suprachoroidal space of an immunocompromised choroidal cell injury rat model. Significantly more donor cells were retained and survived in eyes that received cell laden hydrogels versus contralateral hydrogel free controls. Furthermore, donor cells positive for human nuclear antigen were identified in the choroid of hydrogel eyes only. These findings pave the way for future cell replacement studies in large animal models of choroidal cell dropout focused on evaluating functional integration of donor cells within decellularized vascular tubes. STATEMENT OF SIGNIFICANCE: Age related macular degeneration (AMD) is a leading cause of untreatable blindness in the industrial world. A key pathologic step in AMD is loss of the choriocapillaris endothelial cells, which provide vascular support to the overlying retina. Choroidal cell replacement early in disease may prevent retinal cell death and subsequent vision loss. In this study, we present a strategy for repopulating the choriocapillaris using choroidal endothelial cell laden hydrogels. Specifically, we demonstrate the synthesis and characterization of 3 different laminin-based hydrogel systems. LN111 and LN121 hydrogels were found to have excellent biocompatibility both in vitro and in vivo. Hydrogel mediated delivery of iPSC-derived choroidal endothelial cells enhanced donor cell retention and survival, paving the way for functional large animal studies.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Retinal Diseases and Treatments · Retinopathy of Prematurity Studies · Retinal Development and Disorders
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (80)
Show source-provided references
1. Early changes in gene expression induced by blue light irradiation of A2E-laden retinal pigment epithelial cells10.1111/aos.12146 ↗
2. G. age-related eye disease study research, a randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 810.1001/archopht.119.10.1417 ↗
3. The age-related eye disease study (AREDS): design implications. AREDS report no. 110.1016/S0197-2456(99)00031-8 ↗
4. The age-related eye disease study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1)10.1016/j.ophtha.2012.05.027 ↗
5. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials10.1016/S0140-6736(23)01520-9 ↗
6. Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: a randomized phase 2 trial10.1016/j.ophtha.2019.07.011 ↗
7. C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2/3 trial10.1016/j.ophtha.2020.08.027 ↗
8. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial10.1016/S0140-6736(23)01583-0 ↗
9. Complement in human disease: approved and up-and-coming therapeutics10.1016/S0140-6736(23)01524-6 ↗
10. Complement inhibition for geographic atrophy: review of salient functional outcomes and perspective
11. Complement factor H in AMD: bridging genetic associations and pathobiology10.1016/j.preteyeres.2017.09.001 ↗
12. AMD and the alternative complement pathway: genetics and functional implications10.1186/s40246-016-0079-x ↗
13. Genetics and age-related macular degeneration: a practical review for the clinician10.2147/OPTH.S109723 ↗
14. Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration10.1167/iovs.10-6476 ↗
15. Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy10.1016/j.preteyeres.2014.11.005 ↗
16. The membrane attack complex in aging human choriocapillaris: relationship to macular degeneration and choroidal thinning10.1016/j.ajpath.2014.07.017 ↗
17. Suprachoroidal drug delivery to the back of the eye using hollow microneedles10.1007/s11095-010-0271-y ↗
18. Intrascleral drug delivery to the eye using hollow microneedles10.1007/s11095-008-9756-3 ↗
19. Ex vivo biomechanical characterization of syringe-needle ejections for intracerebral cell delivery10.1038/s41598-018-27568-x ↗
20. Vitreous substitutes as drug release systems10.1167/tvst.11.9.14 ↗
21. Injectable hydrogels for ophthalmic applications10.1016/j.jconrel.2017.10.031 ↗
22. A hyaluronan-based injectable hydrogel improves the survival and integration of stem cell progeny following transplantation10.1016/j.stemcr.2015.04.008 ↗
23. A hydrogel-based stem cell delivery system to treat retinal degenerative diseases10.1016/j.biomaterials.2009.12.004 ↗
24. Distinctive role of integrin-mediated adhesion in TNF-induced PKB/Akt and NF-kappab activation and endothelial cell survival10.1038/sj.onc.1210354 ↗
25. The role of cell adhesion proteins–laminin and fibronectin–in the movement of malignant and metastatic cells10.1007/BF00050692 ↗
26. The impact of genetic manipulation of laminin and integrins at the blood-brain barrier10.1186/s12987-022-00346-8 ↗
27. Laminins and their receptors in the CNS10.1111/brv.12454 ↗
28. Laminins and retinal vascular development10.4161/cam.22480 ↗
29. The role of basement membrane laminins in vascular function10.1016/j.biocel.2020.105823 ↗
30. Characterization of protein-resistant dextran monolayers10.1016/S0142-9612(99)00270-7 ↗
31. Chitosan as an underrated polymer in modern tissue engineering10.3390/nano11113019 ↗
32. Biocompatibility of chitosan carriers with application in drug delivery10.3390/jfb3030615 ↗
33. Synthetic extracellular matrices with tailored adhesiveness and degradability support lumen formation during angiogenic sprouting10.1038/s41467-021-23644-5 ↗
34. Matrix degradability controls multicellularity of 3D cell migration10.1038/s41467-017-00418-6 ↗
35. Hydrogel network dynamics regulate vascular morphogenesis10.1016/j.stem.2020.08.005 ↗
36. Peptide chitosan/dextran core/shell vascularized 3D constructs for wound healing10.1021/acsami.0c07212 ↗
37. Synthesis and characterization of new injectable and degradable dextran-based hydrogels10.1016/j.polymer.2005.07.089 ↗
38. A self-healing hydrogel as an injectable instructive carrier for cellular morphogenesis10.1016/j.biomaterials.2018.09.003 ↗
39. Patient-specific iPSC-derived photoreceptor precursor cells as a means to investigate retinitis pigmentosa10.7554/eLife.00824 ↗
40. Stepwise differentiation and functional characterization of human induced pluripotent stem cell-derived choroidal endothelial cells10.1186/s13287-020-01903-4 ↗
41. Retinal tropism and transduction of adeno-associated virus varies by serotype and route of delivery (intravitreal, subretinal, or suprachoroidal) in rats10.1089/hum.2020.043 ↗
42. Helper-dependent adenovirus transduces the human and rat retina but elicits an inflammatory reaction when delivered subretinally in rats10.1089/hum.2019.159 ↗
43. Characterization of a novel Pde6b-deficient rat model of retinal degeneration and treatment with adeno-associated virus (AAV) gene therapy10.1038/s41434-022-00365-y ↗
44. Carboxymethyl chitosan: properties and biomedical applications10.1016/j.ijbiomac.2018.09.131 ↗
45. Optimization of carboxymethyl chitosan synthesis using response surface methodology and desirability function10.1016/j.ijbiomac.2016.01.017 ↗
46. Local factor H production by human choroidal endothelial cells mitigates complement deposition: implications for macular degeneration10.1002/path.5867 ↗
47. Generation of an immortalized human choroid endothelial cell line (iChEC-1) using an endothelial cell specific promoter10.1016/j.mvr.2018.12.002 ↗
48. Synthesis, physiochemical characterization, and biocompatibility of a chitosan/dextran-based hydrogel for postsurgical adhesion prevention
49. Enzymatically degradable oxidized dextran–chitosan hydrogels with an anisotropic aligned porous structure10.1039/c3sm52070f ↗
50. Extracellular matrix components regulate cellular polarity and tissue structure in the developing and mature retina10.4103/2008-322X.170354 ↗
51. Laminin β2 chain regulates retinal progenitor cell mitotic spindle orientation via dystroglycan10.1523/JNEUROSCI.0551-18.2018 ↗
52. Insulin-like growth factor-binding protein-5-induced laminin gamma1 transcription requires filamin A10.1074/jbc.M109.061754 ↗
53. Laminin alpha4-null mutant mice develop chronic kidney disease with persistent overexpression of platelet-derived growth factor10.2353/ajpath.2010.090570 ↗
54. A dynamic and self-crosslinked polysaccharide hydrogel with autonomous self-healing ability10.1039/C5SM00587F ↗
55. Injectable polysaccharide hydrogels as biocompatible platforms for localized and sustained delivery of antibiotics for preventing local infections10.1002/mabi.201600347 ↗
56. Injectable and self-healing carbohydrate-based hydrogel for cell encapsulation10.1021/acsami.5b03143 ↗
57. Preparation and characterization of acid resistant double cross-linked hydrogel for potential biomedical applications10.1021/acsbiomaterials.7b00818 ↗
58. A crosslinked dextran sulfate-chitosan nanoparticle for delivery of therapeutic heparin-binding proteins10.1016/j.ijpharm.2021.121287 ↗
59. Anticancer and anti-inflammatory properties of chitin and chitosan oligosaccharides10.3390/jfb6010033 ↗
60. Antimicrobial actions and applications of chitosan10.3390/polym13060904 ↗
61. Antifungal and antioxidant properties of chitosan polymers obtained from nontraditional Polybius Henslowii sources10.3390/md17040239 ↗
62. Topical formulations and wound healing applications of chitosan10.1016/S0169-409X(01)00189-2 ↗
63. Complexation behaviour and stability of Schiff bases in aqueous solution. The case of an acyclic diimino(amino) diphenol and its reduced triamine derivative10.1039/b604211b ↗
64. Structural biology of laminins10.1042/EBC20180075 ↗
65. Engineering hydrogels with affinity-bound laminin as 3D neural stem cell culture systems10.1039/C9BM00348G ↗
66. Screen printing tissue models using chemically cross-linked hydrogel systems: a simple approach to efficiently make highly tunable matrices10.1021/acsbiomaterials.1c00902 ↗
67. Bioorthogonally Cross-linked hyaluronan-laminin hydrogels for 3D neuronal cell culture and biofabrication10.1002/adhm.202102097 ↗
68. A Hydrogel platform that incorporates laminin isoforms for efficient presentation of growth factors – neural growth and osteogenesis
69. Matrigel: history/background, uses, and future applications10.1007/s12079-021-00643-1 ↗
70. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures10.1083/jcb.107.4.1589 ↗
71. Retinal pigment epithelial cells synthesize laminins, including laminin 5, and adhere to them through alpha3- and alpha6-containing integrins10.1167/iovs.05-1590 ↗
72. Laminin-121–recombinant expression and interactions with integrins10.1016/j.matbio.2010.05.004 ↗
73. Differentiation of human embryonic stem cells to endothelial progenitor cells on laminins in defined and Xeno-free systems10.1016/j.stemcr.2016.08.017 ↗
74. The alpha4 laminin subunit regulates endothelial cell survival10.1016/j.yexcr.2003.11.006 ↗
75. Methods to assess shear-thinning hydrogels for application as injectable biomaterials10.1021/acsbiomaterials.7b00734 ↗
76. Animal models of age related macular degeneration10.1016/j.mam.2012.06.003 ↗
77. Ribosome inactivating protein saporin induces apoptosis through mitochondrial cascade, independent of translation inhibition10.1016/j.biocel.2008.06.004 ↗
78. The unusual stability of saporin, a candidate for the synthesis of immunotoxins10.1006/bbrc.1997.6597 ↗
79. Small molecule compounds with good anti-inflammatory activity10.1080/14756366.2021.1984903 ↗
80. VEGFR1 signaling in retinal angiogenesis and microinflammation10.1016/j.preteyeres.2021.100954 ↗